BioPharma Resources

Drug Trial Radar · NCT07284602

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,100

Planned (sponsor's estimate)

Start

Jun 26, 2026

Primary completion

Nov 2029

Study completion Dec 2029

Sponsor

Lead sponsor
PureTechIndustry
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study for adults with a lung disease called idiopathic pulmonary fibrosis. The main purpose of this study is to look at how well deupirfenidone improves lung function and how safe it is for people with idiopathic pulmonary fibrosis (IPF) when compared with pirfenidone. Participants may have been treated with an approved antifibrotic drug for up to a year in the past, but they cannot be on background antifibrotic treatment during this study. Participants will be randomly assigned (meaning by chance) to take either deupirfenidone or pirfenidone 3 times a day, and neither a participant nor their study team will know which study drug participants are on. Participants will be in the study for up to approximately 3 years. During the first year, participants visit the study site up to ten times and afterwards they visit the site every three months. All participants will remain on blinded study drug until the last participant has completed Week 52 Visit. They will have lung function tests, a check of their health, and will tell the study team about any unfavorable effects.

Conditions

  • Idiopathic Pulmonary Fibrosis (IPF)

Interventions

  • DeupirfenidoneDrug

    size AA Swedish orange capsule

  • Pirfenidone (PFD)Drug

    size AA Swedish orange capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute change in forced vital capacity (FVC) measured in mLTime frame: Baseline to Week 52

Locations

18 sites in 2 countries. Site status is shown where the registry gives one.

  • Palmtree Clinical Research Inc.

    Palm Spring, California · Recruiting

  • Paradigm Clinical Research Centers LLC

    Redding, California · Recruiting

  • Harmony Medical Research Institute, Inc

    Hialeah, Florida · Recruiting

  • Clinical Research Specialists, LLC

    Kissimmee, Florida · Recruiting

  • Infinity Medical Research

    North Dartmouth, Massachusetts · Recruiting

  • Renown Regional Medical Center

    Reno, Nevada · Recruiting

  • Pulmonix LLC

    Greensboro, North Carolina · Recruiting

  • Clinical Research Associates of Central PA

    DuBois, Pennsylvania · Recruiting

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina · Recruiting

  • Clinical Trials Center of Middle Tennesee LLC

    Franklin, Tennessee · Recruiting

  • StatCare Pulmonary Consultants

    Knoxville, Tennessee · Recruiting

  • Horizon Clinical Research Group.

    Cypress, Texas · Recruiting

  • Premier Pulmonary Critical Care and Sleep Medicine

    Denison, Texas · Recruiting

  • Renovatio Clinical

    El Paso, Texas · Recruiting

  • Renovatio Clinical

    The Woodlands, Texas · Recruiting

  • Renovatio Clinical

    Webster, Texas · Recruiting

  • Dynamic Drug Advancement Limited

    Ajax, Ontario, Canada · Recruiting

  • Dr. Syed Anees Medicine Professional Corporation

    Windsor, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.